0001140859 false 0001140859 2023-06-09 2023-06-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 9, 2023

 

 

AmerisourceBergen Corporation

(Exact name of registrant as specified in its charter)

 

 

Commission File Number: 1-6671

 

Delaware   23-3079390

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)   Identification No.)
     

1 West First Avenue
Conshohocken PA

 

19428-1800

(Address of principal executive offices)

 

(Zip Code)

 

(610) 727-7000

(Registrant’s telephone number, including area code) 

 

Not Applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of exchange on which
registered
Common stock ABC New York Stock Exchange (NYSE)

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 7.01 Regulation FD Disclosure.

 

On June 9, 2023, AmerisourceBergen Corporation (the “Company”) issued a press release announcing that TPG, a global alternative asset management firm (“TPG”), and the Company completed their previously announced acquisition of OneOncology, a network of oncology practices (“OneOncology”). A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

The information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 hereto, is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. This information shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing.

 

Item 8.01 Other Events.

 

On June 9, 2023, TPG and the Company completed their previously announced acquisition of OneOncology through a joint venture in which the Company purchased a minority equity interest.

 

Item 9.01 Financial Statements and Exhibits.

 

(d)  Exhibits.

 

Exhibit Number   Description of Exhibit
99.1.   News Release of AmerisourceBergen Corporation and TPG, dated June 9, 2023.
104   Cover Page Interactive Data File (formatted as inline XBRL)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  AMERISOURCEBERGEN CORPORATION
     
Date:  June 9, 2023 By: /s/ James F. Cleary
  Name: James F. Cleary
  Title: Executive Vice President and Chief Financial Officer

 

 

 

Exhibit 99.1

 

  PRESS RELEASE
  AmerisourceBergen Corporation
  1 West First Avenue
Conshohocken, PA 19428
 

TPG and AmerisourceBergen Announce Completion of Acquisition of ONEONCOLOGY

 

CONSHOHOCKEN, PA, SAN FRANCISCO AND FORT WORTH, TEXAS June 9, 2023 — TPG (NASDAQ: TPG), a global alternative asset management firm, and AmerisourceBergen Corporation (NYSE: ABC) today announced the completion of their previously announced acquisition of OneOncology, a network of leading oncology practices.

 

TPG has acquired a majority interest in OneOncology, and AmerisourceBergen has acquired a minority interest in the company. OneOncology’s affiliated practices, physicians, and management team have also retained a minority interest in the company. The partnership provides OneOncology with additional resources to grow its platform and invest behind clinical, operational, and technical capabilities to continue to deliver high-quality, comprehensive patient care.

 

About TPG

 

TPG is a leading global alternative asset management firm, founded in San Francisco in 1992, with $137 billion of assets under management and investment and operational teams around the world. TPG invests across five multi-strategy platforms: Capital, Growth, Impact, Real Estate, and Market Solutions and our unique strategy is driven by collaboration, innovation, and inclusion. Our teams combine deep product and sector experience with broad capabilities and expertise to develop differentiated insights and add value for our fund investors, portfolio companies, management teams, and communities. For more information, visit www.tpg.com or on Twitter @TPG.

 

About AmerisourceBergen

 

AmerisourceBergen is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 44,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500 and #21 on the Global Fortune 500 with more than $200 billion in annual revenue.

 

 

 

 

Investors:Bennett S. Murphy
Senior Vice President, Head of Investor Relations & Treasury
 610-727-3693
 bmurphy@amerisourcebergen.com

 

 TPG
Leslie Shribman and Courtney Power
 media@tpg.com

 

2